Skip to main content
Swing Capital

Kwality Pharmaceuticals Ltd

NSE: KPL BSE: 539997Pharma

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products[1]

₹1,803
52W: ₹810 — ₹1854
PE 32.7 · Book ₹281 · +542% vs book
Market Cap₹1,871 Cr
Stock P/E32.7Price to Earnings
ROCE18.2%Return on Capital
ROE16.2%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company is expected to give good quarter
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 15.5%
  • +Company's median sales growth is 24.0% of last 10 years

Weaknesses

  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Company has high debtors of 154 days.

Shareholding Pattern

Promoters54.87%
FIIs2.79%
DIIs0.36%
Public41.99%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters54.82%54.82%54.82%54.82%54.82%54.82%54.82%54.87%▲0.0
FIIs0%0%0%0%0%0%0.5%▲0.52.79%▲2.3
DIIs0%0.02%▲0.00.03%▲0.00.32%▲0.30.33%▲0.00.33%0.33%0.36%▲0.0
Public45.18%45.15%▼0.045.14%▼0.044.86%▼0.344.86%44.83%▼0.044.33%▼0.541.99%▼2.3

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales707892809084116111111123
Expenses54617163706790878693
Operating Profit15172117201826242530
OPM %22%21%23%22%22%21%22%22%23%24%
Net Profit68488914121416
EPS ₹6.037.424.348.078.188.2313.9711.513.6115.43

AI Insights

Revenue Trend

TTM revenue at ₹462Cr, up 24.9% YoY. OPM at 23%.

Debt Position

Borrowings at ₹110Cr. Debt-to-equity ratio: 0.39x. Healthy balance sheet.

Institutional Flow

DIIs: 0.36% (+0.35pp change). FIIs: 2.79% (+2.79pp change). Promoters hold 54.87%.

Margin & Efficiency

ROCE improving from 12% (Mar 2014) to 18% (Mar 2025). Working capital days: 100.

Valuation

PE 32.7x with 18.2% ROCE. Price is 542% above book value of ₹281. Dividend yield: 0%.

Recent Announcements